Novartis to present on digital transformation in clinical research LONDON --(BUSINESS WIRE)--Apr. 24, 2018-- Medidata (NASDAQ: MDSO) is hosting the final European NEXT conference in London this week, with executives presenting from Novartis , aparito, and the global life sciences community.
Total revenue of $149.2 million , representing 17% year-over-year growth GAAP operating margin of 8.9%; non-GAAP operating margin of 22.9%, representing 120 basis points year-over-year margin expansion Total multi-year subscription backlog, unadjusted for renewals, of $1.0 billion as of March 31,
NEW YORK --(BUSINESS WIRE)--Apr. 5, 2018-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the market on Thursday, April 19, 2018
Leading Australian clinical trials centre adopts Medidata Clinical Cloud ® to accelerate clinical research SYDNEY & NEW YORK --(BUSINESS WIRE)--Apr. 3, 2018-- Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of
Where Life Sciences Leaders Meet Transformative Technology Meets the Future LONDON --(BUSINESS WIRE)--Mar. 28, 2018-- Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt , with executives from global life sciences and pharmaceutical companies presenting, including
NEW YORK --(BUSINESS WIRE)--Mar. 15, 2018-- Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times (25.9%
NEW YORK --(BUSINESS WIRE)--Feb. 21, 2018-- Medidata (NASDAQ:MDSO) today announced that Tarek Sherif , chief executive officer, and Rouven Bergmann , chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018 , at 11:15 a.m.
Company adopts Edge CTMS in Japan as part of rapid global expansion NEW YORK --(BUSINESS WIRE)--Feb. 20, 2018-- Santen Pharmaceutical Co., Ltd , is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial
Industry-leading Data Management Provider Adopts Rave Imaging to Optimize Workflow, Simplify Image and Data Collection, and Improve Efficiency in Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 15, 2018-- Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC , an
NEW YORK --(BUSINESS WIRE)--Feb. 14, 2018-- Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “ 100 Most Sustainable Companies ” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.